A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs - Contacts and Locations

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

This study has been completed.

Study NCT00002369. Last updated on October 1, 2007. Information provided by Bristol-Myers Squibb

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002369

Locations


United States, Alabama
	Univ of Alabama at Birmingham
	Birmingham, Alabama, United States, 35294

United States, Florida
	Infectious Disease Research Institute Inc
	Tampa, Florida, United States, 33614
	HIV Clinical Research Ctr
	Fort Lauderdale, Florida, United States, 33316

United States, Georgia
	Advance Clinical Research
	Atlanta, Georgia, United States, 30327

United States, Louisiana
	Louisiana State Univ Med Ctr / HIV Outpatient Clinic
	New Orleans, Louisiana, United States, 70112

United States, Massachusetts
	Community Research Initiative of New England
	Brookline, Massachusetts, United States, 02445
	Boston Univ Med Ctr Hosp / Evans - 556
	Boston, Massachusetts, United States, 02118

United States, Missouri
	Washington Univ School of Medicine
	St Louis, Missouri, United States, 63108

United States, Texas
	Blackstock Family Health Ctr
	Austin, Texas, United States, 76751

Puerto Rico
	Hosp Regional de Ponce - Area Vieja
	Ponce, Puerto Rico, 00731
	San Juan AIDS Program
	Santurce, Puerto Rico, 00908

Sponsors and Collaborators

Bristol-Myers Squibb